. 2014 Mar 25;9(3):e93000. doi: 10.1371/journal.pone.0093000

Table 8. Effect of BF on the level of hepatic MDA and SOD activity in mice treated with CCl₄.

Groups	MDA	SOD Activity
	(nmoL/mg protein)	(U/mg protein)
Control	7.39±1.45^a	265.630±18.375^a
CCl₄	15.65±1.89^d	96.802±10.368^e
Berberine 40 mg/kg+CCl₄	8.12±1.83^a	221.728±19.472^b
BF 100 mg/kg+CCl₄	13.64±1.98^c	115.657±10.670^d
BF 300 mg/kg+CCl₄	11.81±1.63^b	117.358±11.964^d
BF 900 mg/kg+CCl₄	8.25±1.76^a	185.577±14.845^c

Each value in the table is represented as Mean ± SD (n = 8). Means not sharing the same letter are significantly different at P<0.05 probability level in each column.

Table 8. Effect of BF on the level of hepatic MDA and SOD activity in mice treated with CCl4.

Table 8. Effect of BF on the level of hepatic MDA and SOD activity in mice treated with CCl₄.